Page last updated: 2024-08-23

alovudine and levoleucovorin

alovudine has been researched along with levoleucovorin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benezra, R; Blasberg, RG; Escorcia, FE; Henke, E; McDevitt, MR; Scheinberg, DA; Smith-Jones, P; Villa, CH	1
Hong, YS; Kim, HJ; Kim, HO; Kim, JS; Kim, KP; Kim, TW; Lee, JL; Lee, SJ; Moon, DH; Oh, SJ; Ryu, JS	1
Aboagye, EO; Doblas, S; Döring, C; Faber, C; Fricke, IB; Griffiths, JR; Heinzmann, K; Heller, A; Hermann, S; Honess, DJ; Jacobs, AH; Just, N; Rieder, N; Schäfers, KP; Schelhaas, S; Schneider, R; Sinkus, R; Smith, DM; Wachsmuth, L	1

Trials

1 trial(s) available for alovudine and levoleucovorin

Article	Year
3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Positron-Emission Tomography; Survival Analysis; Time Factors; Treatment Outcome	2013

Article

Year

3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Positron-Emission Tomography; Survival Analysis; Time Factors; Treatment Outcome

2013

Other Studies

2 other study(ies) available for alovudine and levoleucovorin

Article	Year
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors. Cancer research, 2010, Nov-15, Volume: 70, Issue:22 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dideoxynucleosides; Drug Synergism; Female; Fluorine Radioisotopes; Fluorouracil; Humans; Indium Radioisotopes; Leucovorin; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Tumor Burden; Xenograft Model Antitumor Assays	2010
Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'- Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:7 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artifacts; Biological Transport; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Female; Fluorouracil; HCT116 Cells; Humans; Leucovorin; Mice; Organoplatinum Compounds; Thymidine	2018

Article

Year

Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.

Cancer research, 2010, Nov-15, Volume: 70, Issue:22

Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dideoxynucleosides; Drug Synergism; Female; Fluorine Radioisotopes; Fluorouracil; Humans; Indium Radioisotopes; Leucovorin; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Tumor Burden; Xenograft Model Antitumor Assays

2010

Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:7

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artifacts; Biological Transport; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Female; Fluorouracil; HCT116 Cells; Humans; Leucovorin; Mice; Organoplatinum Compounds; Thymidine

2018